共 41 条
- [34] Long-term (three years) effect of estrogen replacement therapy on major adverse cardiac events in postmenopausal women after intracoronary stenting AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (03): : 330 - +
- [35] Polymorphisms in the CYP19 and AR Genes—Relation to Bone Mass and Longitudinal Bone Changes in Postmenopausal Women With or Without Hormone Replacement Therapy: The Danish Osteoporosis Prevention Study Calcified Tissue International, 2004, 74 : 25 - 34
- [38] Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor κB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (02): : 357 - 362
- [40] The Relationship between Changes in the Production of Osteoprotegerin (OPG), Soluble Receptor Activator for Nuclear Factor κB Ligand (sRANKL) by Whole Blood Cells and Changes in Bone Mineral Density after Estrogen-Progestogen Therapy in Postmenopausal Women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1217 - 1217